Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Rebillard

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Urology|January 20, 2010
Stage pT0 after radical prostatectomy with previous positive biopsy sets: a multicenter studyThomas Bessède, Michel Soulié, Nicolas Mottet, et al.
European Urology|December 19, 2006
Seasonality of serum prostate-specific antigen levels: a population-based studyGilles Salama, Olivier Noirot, Vincent Bataille, et al.
Anticancer Research|December 1, 2010
A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancerDamien Pouessel, Helena Huguet, François Iborra, et al.
Anticancer Research|June 25, 2003
Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot studyStéphane Culine, Xavier Rebillard, Francois Iborra, et al.
The French Journal of Urology|June 1, 2024
Parietal complications after cystectomy: Incisional and parastomal hernia, epidemiology and risk factorsGuillaume Aujoulat, Stéphane Droupy, Rodolphe Thuret, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 16, 2010
Cost study of the clinical management of prostate cancer in France: results on the basis of population-based dataLaurent Molinier, Christel Castelli, Eric Bauvin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancerHeidi Schwarzenbach, Catherine Alix-Panabières, Imke Müller, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2013
Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trialDavid Azria, Olivier Riou, Xavier Rebillard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[Place of contrast imaging in prostate cancer detection]François Cornud, Xavier Rebillard, Arnauld Villers, et al.
World Journal of Urology|March 31, 2015
Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional surveyMehdi Mokhtar Ariane, Guillaume Ploussard, Xavier Rebillard, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Urology|January 20, 2010
Stage pT0 after radical prostatectomy with previous positive biopsy sets: a multicenter studyThomas Bessède, Michel Soulié, Nicolas Mottet, et al.
European Urology|December 19, 2006
Seasonality of serum prostate-specific antigen levels: a population-based studyGilles Salama, Olivier Noirot, Vincent Bataille, et al.
Anticancer Research|December 1, 2010
A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancerDamien Pouessel, Helena Huguet, François Iborra, et al.
Anticancer Research|June 25, 2003
Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot studyStéphane Culine, Xavier Rebillard, Francois Iborra, et al.
The French Journal of Urology|June 1, 2024
Parietal complications after cystectomy: Incisional and parastomal hernia, epidemiology and risk factorsGuillaume Aujoulat, Stéphane Droupy, Rodolphe Thuret, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 16, 2010
Cost study of the clinical management of prostate cancer in France: results on the basis of population-based dataLaurent Molinier, Christel Castelli, Eric Bauvin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancerHeidi Schwarzenbach, Catherine Alix-Panabières, Imke Müller, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2013
Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trialDavid Azria, Olivier Riou, Xavier Rebillard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[Place of contrast imaging in prostate cancer detection]François Cornud, Xavier Rebillard, Arnauld Villers, et al.
World Journal of Urology|March 31, 2015
Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional surveyMehdi Mokhtar Ariane, Guillaume Ploussard, Xavier Rebillard, et al.
Pageof 7